{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:11:00Z","timestamp":1792062660834,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Autism Dev Disord"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1023\/a:1005559725475","type":"journal-article","created":{"date-parts":[[2002,12,21]],"date-time":"2002-12-21T22:31:09Z","timestamp":1040509869000},"page":"451-459","source":"Crossref","is-referenced-by-count":81,"title":["Pharmacotherapy for Hyperactivity in Children with Autism and Other Pervasive Developmental Disorders"],"prefix":"10.1007","volume":"30","author":[{"given":"Michael G.","family":"Aman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen S.","family":"Langworthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"226789_CR1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF01538326","volume":"12","author":"M. G. Aman","year":"1982","unstructured":"Aman, M. G. (1982). Stimulant drug effects in developmental disorders and hyperactivity: Toward a resolution of disparate findings. Journal of Autism and Developmental Disorders, 12, 385\u2013398.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"226789_CR2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF02578400","volume":"8","author":"M. G. Aman","year":"1996","unstructured":"Aman, M. G. (1996). Stimulant drugs in the developmental disabilities revisited. Journal of Developmental and Physical Disabilities, 8, 347\u2013365.","journal-title":"Journal of Developmental and Physical Disabilities"},{"key":"226789_CR3","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1097\/00004583-199512000-00018","volume":"34","author":"M. G. Aman","year":"1995","unstructured":"Aman, M. G., Van Bourgondien,, M. E., Wolford, P. C., & Sarphare, G. (1995). Psychotropic and anticonvulsant drugs in subjects with autism: Prevalence and patterns of use. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1672\u20131681.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"226789_CR4","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association.","year":"1994","unstructured":"American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.","edition":"4th ed."},{"key":"226789_CR5","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1176\/ajp.141.10.1195","volume":"141","author":"L. T. Anderson","year":"1984","unstructured":"Anderson, L. T., Campbell, M., Grega, D. M., Perry, R., Small, A. M., & Green, W. H. (1984). Haloperidol in the treatment of infantile autism: Effects on learning and behavioral symptoms. American Journal of Psychiatry, 141, 1195\u20131202.","journal-title":"American Journal of Psychiatry"},{"key":"226789_CR6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02211843","volume":"19","author":"L. T. Anderson","year":"1989","unstructured":"Anderson, L. T., Campbell, M., Adams, P., Small, A. M., Perry, R., & Shell, J. (1989). The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. Journal of Autism and Development Disorders, 19, 227\u2013239.","journal-title":"Journal of Autism and Development Disorders"},{"key":"226789_CR7","first-page":"124","volume":"90","author":"J. L. Barron","year":"1985","unstructured":"Barron, J. L., & Sandman, C. A. (1985). Paradoxical excitement to sedative-hypnotic drugs in mentally retarded clients. American Journal of Mental Deficiency, 90, 124\u2013129.","journal-title":"American Journal of Mental Deficiency"},{"key":"226789_CR8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00004583-198803000-00020","volume":"27","author":"B. Birmaher","year":"1988","unstructured":"Birmaher, B., Quintana, H., & Greenhill, L. L. (1988). Methylphenidate treatment of hyperactive autistic children. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 248\u2013251.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"226789_CR9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0002-7138(09)61017-7","volume":"17","author":"M. Campbell","year":"1978","unstructured":"Campbell, M., Anderson, L. T., Meier, M., Cohen, I. L., Small, A. M., Samit, C., & Sachar, E. J. (1978). A comparison of haloperidol and behavior therapy and their interaction in autistic children. Journal of the American Academy of Child Psychiatry, 17, 640\u2013655.","journal-title":"Journal of the American Academy of Child Psychiatry"},{"key":"226789_CR10","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00004583-199311000-00024","volume":"32","author":"M. Campbell","year":"1993","unstructured":"Campbell, M., Anderson, L. T., Small, A. M., Adams, P., Gonzalez, N. M., & Ernst, M. (1993). Naltrexone in autistic children: Behavioral symptoms and attentional learning. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1283\u20131291.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"226789_CR11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF01538168","volume":"2","author":"M. Campbell","year":"1972","unstructured":"Campbell, M., Fish, B., David, R., Shapiro, T., Collins, P., & Koh, C. (1972). Response to tri-iodothyronine and dextroamphetamine: A study of preschool schizophrenic children. Journal of Autism and Childhood Schizophrenia, 2, 343\u2013358.","journal-title":"Journal of Autism and Childhood Schizophrenia"},{"key":"226789_CR12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00004583-198903000-00009","volume":"28","author":"M. Campbell","year":"1989","unstructured":"Campbell, M., Overall, J. E., Small, A. M., Sokol, M. S., Spencer, E. K., Adams, P., Foltz, R. L., Monti, K. M., Perry, R., Nobler, M., & Roberts, E. (1989). Naltrexone in autistic children: An acute open dose range tolerance trial. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 200\u2013206.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"226789_CR13","first-page":"70","volume":"19","author":"M. Campbell","year":"1976","unstructured":"Campbell, M., Small, A. M., Collins, P. J., Friedman, E., David, R., & Genieser, N. (1976). Levodopa and levoamphetamine: A crossover study in young schizophrenic children. Current Therapeutic Research, 19, 70\u201386.","journal-title":"Current Therapeutic Research"},{"key":"226789_CR14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1023\/A:1026008602540","volume":"28","author":"S. H. Fatemi","year":"1998","unstructured":"Fatemi, S. H., Realmuto, G. M., Khan, L., & Thuras, P. (1998). Fluoxetine in treatment of adolescent patients with autism: A longitudinal open trial. Journal of Autism and Developmental Disorders, 28, 303\u2013307.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"226789_CR15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/cap.1996.6.177","volume":"6","author":"S. Fisman","year":"1996","unstructured":"Fisman, S., & Steele, M. (1996). Use of risperidone in pervasive developmental disorders: A case series. Journal of Child and Adolescent Psychopharmacology, 6, 177\u2013190.","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"226789_CR16","first-page":"77","volume":"53","author":"M. P. Frankhauser","year":"1991","unstructured":"Frankhauser, M. P., Karumanchi, V. C., German, M. L., Yates, A., & Karumanchi, S. D. (1991). A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. Journal of Clinical Psychiatry, 53, 77\u201382.","journal-title":"Journal of Clinical Psychiatry"},{"key":"226789_CR17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1176\/ajp.138.3.388","volume":"138","author":"B. Geller","year":"1981","unstructured":"Geller, B., Guttmacher, L. B., & Bleeg, M. (1981). Coexistence of childhood onset pervasive developmental disorder and attention deficit disorder with hyperactivity. American Journal of Psychiatry, 138, 388\u2013389.","journal-title":"American Journal of Psychiatry"},{"key":"226789_CR18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1176\/ajp.149.3.363","volume":"149","author":"C. T. Gordon","year":"1992","unstructured":"Gordon, C. T., Rapoport, J. L., Hamburger, S. D., State, R. C., & Mannheim, G. B. (1992). Differential response of seven subjects with autistic disorder to clomipramine and desipramine. American Journal of Psychiatry, 149, 363\u2013366.","journal-title":"American Journal of Psychiatry"},{"key":"226789_CR19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archpsyc.1993.01820180039004","volume":"50","author":"C. T. Gordon","year":"1993","unstructured":"Gordon, C. T., State, R. C., Nelson, J. E., Hamburger, S. D., & Rapoport, J. L. (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50, 441\u2013447.","journal-title":"Archives of General Psychiatry"},{"key":"226789_CR20","unstructured":"Handen, B. L., Johnson, C. R., & Lubetsky, M. (in press). Efficacy of methylphenidate among children with autism and symptoms of ADHD. Journal of Autism and Developmental Disorders."},{"key":"226789_CR21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1025854532079","volume":"27","author":"J. P. Horrigan","year":"1997","unstructured":"Horrigan, J. P., & Barnhill, L. J. (1997). Risperidone and explosive aggressive autism. Journal of Autism and Developmental Disorders, 27, 313\u2013323.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"226789_CR22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00004714-199210000-00005","volume":"12","author":"C. A. Jaselskis","year":"1992","unstructured":"Jaselskis, C. A., Cook, E. H., Fletcher, K. E., & Leventhal, B. L. (1992). Clonidine treatment of hyperactive and impulsive children with autistic disorder. Journal of Clinical Psychopharmacology, 12, 322\u2013327.","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"226789_CR23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1176\/ajp.145.3.335","volume":"145","author":"P. T. Joshi","year":"1988","unstructured":"Joshi, P. T., Capozzoli, J. A., & Coyle, J. T. (1988). Low-dose neuroleptic therapy for children with childhood-onset pervasive developmental disorder. American Journal of Psychiatry, 145, 335\u2013338.","journal-title":"American Journal of Psychiatry"},{"key":"226789_CR24","unstructured":"King, B. H., Wright, D. M., Handen, B. L., Sikich, L., Zimmerman, A.W., MacMahon, W., Cantwell, E., Davanzo, P. A., Dourish, C., Dykens, E. M., Jaselskis, C. A. Leventhal, B. L., Lubetsky, M. J., Myers, S. M., Ozonoff, S., Shah, B. G., Leavitt, J., Shape, M., Steele, E. W., Williamson, K., & Cook, Jr., E. H. (1999, October). A double blind placebo controlled study of amantadine hydrochloride in treatment of children with autistic disorder. Poster presentation given at the 46th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Chicago, IL."},{"key":"226789_CR25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00004583-199502000-00018","volume":"34","author":"B. K. Kolmen","year":"1995","unstructured":"Kolmen, B. K., Feldman, H., Handen, B. L., & Janosky, J. E. (1995). Naltrexone in young autistic children: A double bind placebo-controlled crossover study. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 223\u2013231.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"226789_CR26","first-page":"1570","volume":"36","author":"B. K. Kolmen","year":"1997","unstructured":"Kolmen, B. K., Feldman, H., Handen, B. L., & Janosky, J. E. (1997). Naltrexone in young autistic children: Replication study and learning measures. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1570\u20131578.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"226789_CR27","first-page":"119","volume":"27","author":"J. J. Locascio","year":"1991","unstructured":"Locascio, J. J., Malone, R. P., Small, A. M., Kafantaris, V., Ernst, M., Lynch, N. S., Overall, J. E., & Campbell, M. (1991). Factors related to haloperidol response and dyskinesias in autistic children. Psychopharmacology Bulletin, 27, 119\u2013126.","journal-title":"Psychopharmacology Bulletin"},{"key":"226789_CR28","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1037\/0033-2909.86.6.1236","volume":"86","author":"O. I. Lovaas","year":"1979","unstructured":"Lovaas, O. I., Koegel, R. L., & Schreibman, L. (1979). Stimulus overselectivity in autism: A review of research. Psychological Bulletin, 86, 1236\u20131254.","journal-title":"Psychological Bulletin"},{"key":"226789_CR29","volume-title":"Current developments in psychopharmacology (Vol. 2)","author":"M. Lyon","year":"1975","unstructured":"Lyon, M., & Robbins, T. (1975). The action of central nervous system stimulant drugs: A general theory concerning amphetamine effects. In W. B. Essman & L. Valzelli (Eds.), Current developments in psychopharmacology (Vol. 2). New York: Spectrum."},{"key":"226789_CR30","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00004583-199809000-00006","volume":"37","author":"P. Malek-Ahmadi","year":"1998","unstructured":"Malek-Ahmadi, P., & Simonds, J. F. (1998). Olanzapine for autistic disorder with hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 902.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"226789_CR31","first-page":"355","volume":"3","author":"F. Marrosu","year":"1987","unstructured":"Marrosu, F., Marrosu, G., Rachel, M. G., & Biggio, G. (1987). Paradoxical reactions elicited by diazepam in children with classic autism. Functional Neurology, 3, 355\u2013361.","journal-title":"Functional Neurology"},{"key":"226789_CR32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00004583-199705000-00020","volume":"36","author":"C. J. McDougle","year":"1997","unstructured":"McDougle, C. J., Holmes, J. P., Bronson, M. R., Anderson, G. M., Volkmar, F. R., Price, L. H., & Cohen, D. J. (1997). Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 685\u2013693.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"226789_CR33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/archfami.6.4.368","volume":"6","author":"L. H. McCormick","year":"1997","unstructured":"McCormick, L. H. (1997). Treatment with buspirone in a patient with autism. Archives of Family Medicine, 6, 368\u2013370.","journal-title":"Archives of Family Medicine"},{"key":"226789_CR34","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00004583-199804000-00014","volume":"37","author":"R. Nicolson","year":"1998","unstructured":"Nicolson, R., Awad, G., & Sloman, L. (1998). An open trial of risperidone in young autistic children. American Academy of Child and Adolescent Psychiatry, 37, 372\u2013376.","journal-title":"American Academy of Child and Adolescent Psychiatry"},{"key":"226789_CR35","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/1097-4679(198809)44:5<708::AID-JCLP2270440507>3.0.CO;2-T","volume":"44","author":"J. E. Overall","year":"1988","unstructured":"Overall, J. E., & Campbell, M. (1988). Behavioral assessment of psychopathology in children: Infantile autism. Journal of Clinical Psychology, 44, 708\u2013716.","journal-title":"Journal of Clinical Psychology"},{"key":"226789_CR36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/cap.1997.7.167","volume":"7","author":"R. Perry","year":"1997","unstructured":"Perry, R., Pataki, C., Munoz-Silva, D. M., Armenteros, J., & Silva, R. R. (1997). Risperidone in children and adolescents with pervasive developmental disorder: Pilot trial and follow-up. Journal of Child and Adolescent Psychopharmacology, 7, 167\u2013179.","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"226789_CR37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004714-199902000-00008","volume":"19","author":"M. N. Potenza","year":"1999","unstructured":"Potenza, M. N., Holmes, J. P., Kanes, S. J., & McDougle, C. J. (1999). Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study. Journal of Clinical Psychopharmacology, 19, 37\u201344.","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"226789_CR38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF02179289","volume":"25","author":"H. Quintana","year":"1995","unstructured":"Quintana, H., Birmaher, B., Stedge, D., Lennon, S., Freed, J., Bridge, J., & Greenhill, L. (1995). Use of methylphenidate in the treatment of children with autistic disorder. Journal of Autism and Developmental Disorders, 25, 283\u2013294.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"226789_CR39","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archpsyc.1980.01780210091010","volume":"37","author":"J. L. Rapoport","year":"1980","unstructured":"Rapoport, J. L., Buchsbaum, M. S., Weingartner, H., Zahn, T. P., Ludlow, C., & Mikkelsen, E. J. (1980). Dextro-amphetamine: Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Archives of General Psychiatry, 37, 933\u2013943.","journal-title":"Archives of General Psychiatry"},{"key":"226789_CR40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00004714-198904000-00009","volume":"9","author":"G. M. Realmuto","year":"1989","unstructured":"Realmuto, G. M., August, G. J., & Garfinkel, B. D. (1989). Clinical effect of buspirone in autistic children. Journal of Clinical Psychopharmacology, 9, 122\u2013125.","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"226789_CR41","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0028-3908(79)90157-6","volume":"18","author":"T. W. Robbins","year":"1979","unstructured":"Robbins, T. W., & Sahakian, B. J. (1979). \u201cParadoxical\u201d effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology. Neuropharmacology, 18, 931\u2013950.","journal-title":"Neuropharmacology"},{"key":"226789_CR42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF01047433","volume":"4","author":"C. A. Sandman","year":"1992","unstructured":"Sandman, C. A., & Barron, J. L. (1992). Paradoxical response to sedative\/ hypnotics in patients with self-injurious behavior and stereotypy. Journal of Developmental and Physical Disabilities, 4, 307\u2013316.","journal-title":"Journal of Developmental and Physical Disabilities"},{"key":"226789_CR43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00004703-198212000-00014","volume":"3","author":"K. Schmidt","year":"1982","unstructured":"Schmidt, K. (1982). The effect of stimulant medication in childhood-onset pervasive developmental disorder: A case report. Journal of Developmental and Behavioral Pediatrics, 3, 244\u2013246.","journal-title":"Journal of Developmental and Behavioral Pediatrics"},{"key":"226789_CR44","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1176\/ajp.138.7.997b","volume":"138","author":"A. Sporn","year":"1981","unstructured":"Sporn, A., & Pinsker, H. (1981). Use of stimulant medication in treating pervasive developmental disorder. American Journal of Psychiatry, 138, 997.","journal-title":"American Journal of Psychiatry"},{"key":"226789_CR45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00004583-198803000-00019","volume":"27","author":"J. M. Strayhorn","year":"1988","unstructured":"Strayhorn, J. M., Rapp, N., Donina, W., & Strain, P. S. (1988). Randomized trial of methylphenidate for autistic child. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 244\u2013247.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"226789_CR46","first-page":"1517","volume":"138","author":"C. Vitriol","year":"1981","unstructured":"Vitriol, C., & Farber, B. (1981). Stimulant medication in certain childhood disorders. American Journal of Psychiatry, 138, 1517\u20131518.","journal-title":"American Journal of Psychiatry"},{"key":"226789_CR47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/000992288502400301","volume":"24","author":"F. Volkmar","year":"1985","unstructured":"Volkmar, F., Hoder, E. L., & Cohen, D. J. (1985). Inappropriate uses of stimulant medications. Clinical Pediatrics, 24, 127\u2013130.","journal-title":"Clinical Pediatrics"},{"key":"226789_CR48","first-page":"640","volume":"78","author":"D. G. Ullman","year":"1974","unstructured":"Ullman, D. G. (1974). Breadth of attention and retention in mentally retarded and intellectually average children. American Journal of Mental Deficiency, 78, 640\u2013648.","journal-title":"American Journal of Mental Deficiency"},{"key":"226789_CR49","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1055\/s-2008-1073041","volume":"25","author":"P. Uvebrant","year":"1994","unstructured":"Uvebrant, P., & Bauziene, R. (1994). Intractable epilepsy in children. The efficacy of lamotrigine treatment, including nonseizure-related benefits. Neuropediatrics, 25, 284\u2013289.","journal-title":"Neuropediatrics"},{"key":"226789_CR50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-94-011-6701-7_9","volume-title":"The psychobiology of childhood: Profile of current issues","author":"J. S. Werry","year":"1984","unstructured":"Werry, J. S., & Aman, M. G. (1984). Methylphenidate in hyperactive and enuretic children. In B. Shopsin & L. Greenhill (Eds.), The psychobiology of childhood: Profile of current issues (pp. 183\u2013195). Jamaica, NY: Spectrum."},{"key":"226789_CR51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/978-1-4899-0086-9_15","volume-title":"Practitioner's guide to psychoactive drugs for children and adolescents","author":"J. S. Werry","year":"1999","unstructured":"Werry, J. S., & Aman, M. G. (1999). Anxiolytics, sedatives, and miscellaneous drugs. In J. S. Werry & M. G. Aman (Eds.), Practitioner's guide to psychoactive drugs for children and adolescents (2nd ed., pp, 433\u2013469). New York: Plenum Medical Book.","edition":"2nd ed."},{"key":"226789_CR52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1023000929040","volume":"29","author":"S. H. N. Willemsen-Swinkles","year":"1999","unstructured":"Willemsen-Swinkles, S. H. N., Buitelaar, J. K., van Berckelaer-Onnes, I. A., & van Engeland, H. (1999). Brief report: Six months continuation treatment in naltrexone-responsive children with autism: An open-label case-control design. Journal of Autism and Developmental Disorders, 29, 167\u2013169.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"226789_CR53","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0006-3223(95)00297-9","volume":"39","author":"S. H. N. Willemsen-Swinkles","year":"1996","unstructured":"Willemsen-Swinkles, S. H. N., Buitelaar, J. K., & van Engeland, H. (1996). The effects of chronic naltrexone treatment in young autistic children: A double-blind placebo-controlled crossover study. Society of Biological Psychiatry, 39, 1023\u20131031.","journal-title":"Society of Biological Psychiatry"},{"key":"226789_CR54","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0165-1781(95)02749-M","volume":"58","author":"S. H. N. Willemsen-Swinkles","year":"1995","unstructured":"Willemsen-Swinkles, S. H. N., Buitelaar, J. K., Weijnen, F. G., & van Engeland, H. (1995). Placebo-controlled acute dosage naltrexone study in young autistic children. Psychiatry Research, 58, 203\u2013215.","journal-title":"Psychiatry Research"},{"key":"226789_CR55","volume-title":"The ICD-10 classification of mental and behavioural disorders","author":"World Health Organization.","year":"1993","unstructured":"World Health Organization. (1993). The ICD-10 classification of mental and behavioural disorders. Geneva: Author."},{"key":"226789_CR56","volume-title":"Handbook of mental deficiency","author":"D. Zeaman","year":"1963","unstructured":"Zeaman, D., & House, B. J. (1963). The role of attention in retardate discrimination learning. In N. R. Ellis (Ed.), Handbook of mental deficiency. New York: McGraw-Hill."},{"key":"226789_CR57","first-page":"738","volume":"153","author":"A. Zuddas","year":"1996","unstructured":"Zuddas, A., Ledda, M. G., Fratta, A., Muglia, P., & Cianchetti, C. (1996). Clinical effects of clozapine on autistic disorder. American Journal of Psychiatry, 153, 738.","journal-title":"American Journal of Psychiatry"}],"container-title":["Journal of Autism and Developmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005559725475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1005559725475\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005559725475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T08:20:10Z","timestamp":1749111610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1005559725475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["226789"],"URL":"https:\/\/doi.org\/10.1023\/a:1005559725475","relation":{},"ISSN":["0162-3257","1573-3432"],"issn-type":[{"value":"0162-3257","type":"print"},{"value":"1573-3432","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}